Trademark: 97318817
Status Date
Tuesday, April 2, 2024
Registration Number
7342346
Registration Date
Tuesday, April 2, 2024
Filing Date
Friday, March 18, 2022
Published for Opposition
Tuesday, January 16, 2024
5 Pharmaceuticals, in particular pharmaceuticals for treating fibrosis, pharmaceuticals for treating lung diseases, pharmaceuticals for treating inflammatory disorders, pharmaceuticals for treating scars and scar formation, pharmaceuticals for promoting tissue repair and/or tissue regeneration, pharmaceuticals for wound healing, wherein all aforementioned pharmaceuticals include small chemical molecules, peptides, proteins, nucleic acids, cellular products and gene therapy products; Diagnostic reagents, for medical and veterinary purposes
1 Chemicals for use in industry and science, in particular reagents for labelling of biomolecules, reagents for tagging of biomolecules; reagents for non-medical purposes for visualization or detection of biomolecules; reagents for non-medical purposes for tagging of chemical entities or chemical molecules; reagents for non-medical purposes for generation of molecular constructs, transfection reagents, reagents for gene editing; reagents for non-medical purposes for investigations in relation to tissue disorders; reagents for non-medical purposes for investigations in relation to fibrosis; reagents for non-medical purposes for investigations in relation to inflammatory disorders; diagnostic reagents, not for medical or veterinary purposes; chemical reagent mixtures in kit form, other than for medical or veterinary use; Kits comprising reagents for use in scientific research, in particular kits for labelling of biomolecules; kits for non-medical purposes for tagging of biomolecules comprising reagents for tagging of biomolecules; kits for non-medical purposes for visualization or detection of biomolecules comprising reagents for visualization or detection of biomolecules; kits for non-medical purposes for generation of molecular constructs comprising reagents for generation of molecular constructs; transfection kits comprising reagents for transfection of cells; kits for non-medical purposes for gene editing comprising reagents for gene editing; kits for non-medical purposes for investigations in relation to tissue disorders comprising reagents for investigations in relation to tissue disorders; kits for non-medical purposes for investigations in relation to fibrosis comprising reagents for investigations of fibrosis; kits for non-medical purposes for investigations in relation to inflammatory disorders comprising reagents for investigations of inflammatory disorders; diagnostic kits comprising diagnostic reagents for scientific or research use not for medical and veterinary purposes
44 Diagnosis and treatment of fibrosis, lung diseases, or scars or scar formation; Diagnosis and healing of wound; Diagnosis and healing being medical services of wounds; Medical treatment being tissue repair and/or tissue regeneration for treatment of inflammatory conditions; Treatment prediction and diagnostics in the field of medicine and veterinary medicine
42 Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; Biochemical and pharmaceutical laboratory services, in particular in the field of discovery and development of drugs for treating fibrosis, lung diseases, or scars, drugs for preventing scar formation or drugs for wound healing, in the field of discovery of drugs for promoting tissue repair and/or tissue regeneration; Chemical and biochemical analysis of active ingredients in the field of drugs for treating fibrosis, lung diseases, or scars, or in the field of drugs for preventing scar formation or drugs for wound healing, or in the field of drugs for promoting tissue repair and/or tissue regeneration; Scientific research consultancy, in particular with respect to drug discovery methodologies and systems for drug discovery and with respect to drug development methodologies and systems for drug development
Apr 2, 2024
Notice Of Registration Confirmation Emailed
Apr 2, 2024
Registered-Principal Register
Jan 16, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 16, 2024
Published For Opposition
Dec 27, 2023
Notification Of Notice Of Publication E-Mailed
Dec 8, 2023
Approved For Pub - Principal Register
Dec 1, 2023
Teas/Email Correspondence Entered
Dec 1, 2023
Correspondence Received In Law Office
Dec 1, 2023
Assigned To Lie
Jun 28, 2023
Teas Response To Office Action Received
Mar 29, 2023
Application Extension Granted/Receipt Provided
Mar 29, 2023
Application Extension To Response Period - Received
Jan 6, 2023
Notification Of Non-Final Action E-Mailed
Jan 6, 2023
Non-Final Action E-Mailed
Jan 6, 2023
Non-Final Action Written
Dec 30, 2022
Assigned To Examiner
Mar 23, 2022
New Application Office Supplied Data Entered
Mar 22, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
